Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Tatsuya Manabe is a pioneering robotic surgeon whose work is reshaping the landscape of minimally invasive oncologic surgery, particularly for complex digestive and pelvic cancers. His primary research focuses on the implementation and evaluation of next-generation robotic platforms, most notably the hinotori™ Surgical Robot System. Dr. Manabe’s major contribution lies in demonstrating the safe and effective integration of this novel system into clinical practice, even in institutions already proficient with established platforms like da Vinci, as evidenced by his highly cited 2024 work (16 citations). He has also advanced the field through rigorous multicenter, propensity-matched analyses, proving that robotic pelvic exenteration offers outcomes comparable to or better than open and laparoscopic approaches for pelvic cancer (13 citations). Beyond platform validation, Dr. Manabe has refined complex reconstructive techniques, such as the secure robotic transthoracic valvuloplastic esophagogastrostomy by double flap (VPEG-DFT) for esophagogastric junctional cancer—a procedure that dramatically reduces postoperative reflux. With a growing body of work that bridges technological innovation and clinical excellence, Dr. Manabe is establishing new standards for safety and efficacy in robotic surgery, making him a key figure for students and researchers interested in the future of surgical oncology.